UCB
CNS Mission Corporate Partner
About UCB
UCB, Inc., a global biopharmaceutical company focused on improving the lives of people living with severe diseases of the central nervous system and immune system, is a Mission Partner as part of CNS’s Corporate Partnership Program. With a strong foundation in neurology, UCB is focused on advancing innovative therapies and partnering with the healthcare community to address areas of high unmet need, including rare and complex epilepsies.
Commitment to Epilepsy & Rare Syndromes
UCB is committed to supporting patients, caregivers, and healthcare professionals managing developmental and epileptic encephalopathies (DEEs), specifically Dravet syndrome and Lennox-Gastaut Syndrome. Through ongoing research, clinical development, and collaboration with the neurology community, UCB aims to improve seizure outcomes and reduce the burden of disease for patients and families affected by severe epilepsy.
Materials for Healthcare Professionals
Supporting the Dravet Syndrome and Lennox-Gastaut Syndrome Community
UCB works to elevate the voices of patients, caregivers, and healthcare professionals through initiatives that highlight the real-world impact of seizure reduction. Community engagement efforts, such as patient storytelling, are designed to showcase meaningful improvements in daily life and foster greater understanding of treatment outcomes.
Materials for Patients and Caregivers:
Follow us on Facebook and LinkedIn
Learn more
ucb.com
©2026 UCB, Inc., Smyrna, GA 30080. All rights reserved.
US-FA-2600264
This post is sponsored by UCB, Inc.
